An Open-label Extension Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy
- First Posted Date
- 2015-12-09
- Last Posted Date
- 2022-03-09
- Lead Sponsor
- UCB Biopharma SRL
- Target Recruit Count
- 42
- Registration Number
- NCT02625090
- Locations
- 🇧🇪
Ep0073 103, Brussels, Belgium
🇧🇬Ep0073 201, Sofia, Bulgaria
🇪🇸Ep0073 501, Sevilla, Spain
© Copyright 2024. All Rights Reserved by MedPath